山东凯盛新材料股份有限公司 2024 年度财务报告 山东凯盛新材料股份有限公司 2024 年度财务报告 2025 年 3 月 15 日 1 山东凯盛新材料股份有限公司 2024 年度财务报告 第十节 财务报告 一、审计报告 | 审计意见类型 | 标准的无保留意见 | | --- | --- | | 审计报告签署日期 | 2025 年 03 月 13 日 | | 审计机构名称 | 四川华信（集团）会计师事务所（特殊普通合伙） | | 注册会计师姓名 | 陈杰、李鲜、唐秀英 | 审计报告正文 审计报告 川华信审（2025）第 0031 号 山东凯盛新材料股份有限公司全体股东： 一、审计意见 我们审计了山东凯盛新材料股份有限公司（以下简称："凯盛新材"）财务报表，包括 2024 年 12 月 31 日的合并及 母公司资产负债表，2024 年度的合并及母公司利润表、合并及母公司现金流量表、合并及母公司股东权益变动表以及相 关财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的规定编制，公允反映了凯盛新材 2024 年 12 月 31 日 的合并及母公司财务状况以及 2024 年度的合并及母公司经营 ...

公司聘请的外部审计机构四川华信（集团）会计师事务所(特殊普通合伙)（以 下简称"四川华信"）具备从事证券相关业务审计的资格。2024 年度，四川华信 遵循独立、客观、公证的执业准则，勤勉尽责地履行审计职责，能够满足公司审 计工作要求，能够独立对公司财务及内部控制情况进行审计。 二、与外部审计机构讨论与沟通相关事项 2024 年度，公司董事会审计委员会与四川华信沟通协商公司 2024 年度财务 报告的审计事项，确定了审计工作计划，及时了解审计工作进展情况，在四川华 信出具初步审计意见后，与年审会计师进行了沟通，了解整体审计情况，沟通审 计过程中发现的重点问题并协商下一步解决方案。 三、向公司董事会提出续聘外部审计机构的建议 为确保公司年度审计工作的顺利进行及审计工作的延续性，根据四川华信 2024 年度审计工作完成情况及执业质量，经公司董事会审计委员会表决后，向 公司董事会提名四川华信为公司 2025 年度财务审计机构和内部控制审计机构。 山东凯盛新材料股份有限公司 山东凯盛新材料股份有限公司董事会审计委员会 关于对四川华信（集团）会计师事务所(特殊普通合伙) 2024 年度履行监督职责情况报告 根据《深圳证券 ...

| 证券代码：301069 | 证券简称：凯盛新材 公告编号：2025-010 | | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | 山东凯盛新材料股份有限公司 关于召开2024年年度股东大会的通知公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 一、召开会议的基本情况 1、股东大会届次：2024 年年度股东大会。 2、股东大会的召集人：公司董事会。 山东凯盛新材料股份有限公司（以下简称"公司"）第三届董事会第二十九 次会议于 2025 年 3 月 13 日召开，会议审议通过了《关于召开 2024 年年度股东 大会的议案》。 3、会议召开的合法、合规性： 本次股东大会的召集和召开符合《中华人民共和国公司法》《上市公司股东 大会规则》等法律、法规、规范性文件及《公司章程》《股东大会议事规则》的 有关规定。 1 记在册的公司全体股东均有权出席股东大会，并可以以书面形式委托代理人出席 会议和参加表决，该股东代理人不必是本公司股东（授权委托书见附件二）； （2）公司董事、高级管理人员； （3）公司聘请的律师。 4、会议 ...

Financial Performance - In 2024, the company's revenue decreased by 5.97% to ¥927,932,105.81 compared to ¥986,897,245.84 in 2023[22] - The net profit attributable to shareholders dropped by 64.56% to ¥55,987,316.48 from ¥157,989,001.88 in the previous year[22] - The net profit after deducting non-recurring gains and losses fell by 80.56% to ¥29,515,889.67, down from ¥151,859,536.11 in 2023[22] - The basic earnings per share decreased by 64.56% to ¥0.1331 from ¥0.3756 in the previous year[22] - The total assets at the end of 2024 were ¥2,388,723,256.19, a decrease of 3.79% from ¥2,482,942,697.11 in 2023[22] - The company's total revenue for Q1 2024 was approximately ¥239.94 million, Q2 was ¥254.71 million, Q3 was ¥201.35 million, and Q4 was ¥231.94 million[24] - The net profit attributable to shareholders for Q1 2024 was ¥25.70 million, Q2 was ¥28.31 million, Q3 showed a loss of ¥1.76 million, and Q4 was ¥3.74 million[24] - The net profit after deducting non-recurring gains and losses for Q1 2024 was ¥21.68 million, Q2 was ¥20.41 million, Q3 was a loss of ¥6.23 million, and Q4 was a loss of ¥6.34 million[25] - The net cash flow from operating activities for Q1 2024 was ¥13.73 million, Q2 was a negative ¥1.26 million, Q3 was ¥33.62 million, and Q4 was ¥5.64 million[25] Research and Development - The company plans to enhance R&D innovation and improve operational quality to adapt to the changing international environment[4] - The company has increased its R&D investment and improved production processes, focusing on green circular economy practices[35] - The R&D team consists of 195 personnel, including 10 with doctoral degrees, focusing on high-end chemical products and high-performance polymer materials[42] - The company's R&D investment amounted to ¥53,803,033.87 in 2024, representing 5.80% of its operating revenue, an increase from 5.22% in 2023[75] - The total number of R&D personnel increased to 195 in 2024, a rise of 1.56% compared to 192 in 2023[75] Market and Product Development - The company is a leading producer of chlorosulfonic acid and aramid polymer monomers, with significant market influence and established partnerships with major manufacturers in Japan and South Korea[34] - The company is focused on developing new lithium-ion battery electrolyte products and improving production processes, which are expected to positively impact future operations[72] - The company is actively expanding its product lines, including a 1,000 tons/year chlorinated diphenyl sulfone technical transformation project, which is currently in operation[50] - The company is focusing on expanding its product range through the development of new chemical products, including high-purity chlorinated compounds and sulfonated polyether ketones[74] - The company aims to enhance its market competitiveness by optimizing production processes and reducing costs through advanced research and development initiatives[74] Environmental and Safety Management - The company emphasizes safety and environmental management, adhering to various environmental laws and implementing measures to reduce emissions and enhance waste treatment[43] - The company has established an environmental management department and implemented regulations to ensure compliance with environmental laws[107] - The company has implemented a comprehensive safety risk management system, utilizing HAZOP analysis to identify and assess safety risks across processes and facilities[186] - The company has committed to environmental protection by adhering to national and local environmental laws, ensuring that all pollutants were within discharge standards during the reporting period[182] - The company has established an emergency response plan for environmental incidents, enhancing its ability to manage potential pollution risks[173] Corporate Governance - The company has conducted multiple shareholder meetings to ensure compliance with legal requirements and protect shareholder rights[114] - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with governance standards[116] - The company maintains a high level of information disclosure and transparency, utilizing platforms such as China Securities Journal and CNINFO for communication with investors[119] - The company has established an internal control system to regulate management and mitigate risks, ensuring compliance with relevant laws and regulations[118] - The company has not reported any instances of the controlling shareholder interfering with its decision-making or operations, ensuring independence in business and financial matters[122] Financial Management - The company achieved a total cash inflow from operating activities of ¥680,413,405.55, an increase of 11.47% from ¥610,382,741.55 in 2023[77] - The net cash flow from investment activities decreased by 3,161.94% year-on-year, attributed to increased management of financial assets based on operational funding needs[78] - The net cash flow from financing activities fell by 116.27% year-on-year, mainly due to the previous year's issuance of convertible bonds that raised ¥639,730,000[78] - The company reported a credit impairment loss of CNY -14,282,523.01, which is -23.60% of total profit, mainly due to the provision for bad debts on other receivables by subsidiaries[79] - The company has received government subsidies and deferred income amortization contributing CNY 14,795,057.09, which is 24.45% of total profit[79] Production and Operational Efficiency - The company employs a production model of "sales-driven production + strategic inventory," ensuring timely and quality product delivery while adhering to safety and environmental standards[38] - The company has implemented automated control systems in production to ensure stability and safety, alongside energy-saving and quality-enhancing measures[40] - The company has established long-term stable relationships with major suppliers for essential raw materials, ensuring a reliable supply chain[38] - The company has a strong technical accumulation and process advantages, with core technologies in the production, purification, and testing of chlorosulfonic acid and acyl chloride products, achieving a product purity of over 99%[51] - The company has implemented digital and automated upgrades to enhance production efficiency, resulting in a noticeable decrease in steam consumption[176] Strategic Planning - The company will focus on sustainable development and market share expansion as part of its long-term strategy[4] - The strategic development plan includes extending from fine chemicals to high-performance polymer materials and new energy sectors, enhancing overall competitiveness[56] - The company is actively pursuing potential mergers and acquisitions to enhance its product offerings and market reach[129] - The company plans to reduce its chlorosulfonic acid production capacity by 50,000 tons within three years, ensuring that the revenue from chlorosulfonic acid products accounts for less than 15% of its main business income[193] - The company has committed to a long-term strategy of sustainable and efficient development, focusing on green and circular economy practices[103]

| 证券代码：301069 | 证券简称：凯盛新材 公告编号：2025-004 | | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | 山东凯盛新材料股份有限公司 第三届董事会第二十九次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 一、会议召开及议案审议情况 - 1 - （四）会议以 9 票赞成、0 票反对、0 票弃权的表决结果审议通过了《2025 年度预算报告》 山东凯盛新材料股份有限公司（以下简称"公司"）第三届董事会第二十九 次会议通知于 2025 年 3 月 3 日以电子邮件的形式发出，2025 年 3 月 13 日于公 司会议室通过"现场+通讯"的方式召开，公司 9 名董事都参加了本次会议，会 议的通知及召开符合《公司法》及《公司章程》的规定，合法有效。本次会议由 董事长王加荣先生主持，经与会各位董事认真讨论研究，审议并通过了以下议案： （一）会议以 9 票赞成、0 票反对、0 票弃权的表决结果审议通过了《2024 年度总经理工作报告》 （二）会议以 9 票赞成、0 票反对、0 票弃权的表决 ...

山东凯盛新材料股份有限公司（以下简称"公司"）第三届董事会第二十八 次会议通知于 2025 年 2 月 18 日以电子邮件的形式发出，2025 年 2 月 21 日通过 通讯表决的方式召开，公司 9 名董事都参加了本次会议，会议的通知及召开符合 《公司法》及《公司章程》的规定，合法有效。本次会议由公司董事长王加荣先 生主持，经与会各位董事认真讨论研究，以 9 票赞成、0 票反对、0 票弃权的表 决结果审议通过了《关于制定<市值管理制度>的议案》： 为进一步加强公司市值管理工作，维护公司及广大投资者合法权益，公司积 极响应中国证监会《上市公司监管指引第 10 号—市值管理》关于鼓励上市公司 建立市值管理制度的号召，根据《中华人民共和国公司法》《中华人民共和国证 券法》等法律、法规及《深圳证券交易所股票上市规则》及其他相关规定，现决 定制定公司《市值管理制度》。 二、备查文件 第三届董事会第二十八次会议决议。 特此公告。 | 证券代码：301069 | 证券简称：凯盛新材 公告编号：2025-003 | | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | 山东凯盛新材料股份有限公司 ...

Financial Performance Forecast - The company expects a net profit attributable to shareholders of between 47 million and 61 million RMB for 2024, representing a decline of 70.25% to 61.39% compared to the previous year's profit of 157.99 million RMB[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between 24 million and 31 million RMB, a decrease of 84.20% to 79.59% from last year's profit of 151.86 million RMB[4] Reasons for Decline - The decline in performance is attributed to decreased demand in the downstream market and intensified industry competition, leading to a drop in both volume and price of main products[6] - The company incurred interest expenses exceeding 30 million RMB from convertible bond fundraising, contributing to the overall decline in revenue and profit[6] Financial Reporting - The performance forecast is based on preliminary calculations by the company's finance department and has not been audited by an accounting firm[7]

| 证券代码：301069 | 证券简称：凯盛新材 公告编号：2025-001 | | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | 山东凯盛新材料股份有限公司 关于2024年第四季度可转债转股情况的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 特别提示： 根据《深圳证券交易所股票上市规则》和《深圳证券交易所可转换公司债券 业务实施细则》的有关规定，山东凯盛新材料股份有限公司（以下简称"公司"） 现将 2024 年第四季度可转换公司债券（以下简称"可转债"）转股及公司股份变 动的情况公告如下： 一、可转换公司债券上市发行情况 （一）可转换公司债券发行情况 根据中国证券监督管理委员会《关于同意山东凯盛新材料股份有限公司向不 特定对象发行可转换公司债券注册的批复》（证监许可〔2023〕1893 号），山东凯 盛新材料股份有限公司（以下简称"公司"）获准向不特定对象发行可转换公司 债券 650.00 万 张 ， 每 张 面 值 为 人 民 币 100.00 元 ， 募 集 资 金 总 额 为 650,000,00 ...

西南证券股份有限公司关于山东凯盛新材料股份有限公司 经中国证券监督管理委员会 2021 年 8 月 10 日下发的《关于同意山东凯盛新 材料股份有限公司首次公开发行股票注册的批复》（证监许可〔2021〕2626 号）， 同意公司首次公开发行人民币普通股（A 股）股票 6,000 万股，每股面值 1 元， 每股发行价格为人民币 5.17 元，募集资金总额人民币 31,020.00 万元，扣除与发 行有关的费用（不含增值税）人民币 2,830.85 万元，公司实际募集资金净额为人 民币 28,189.15 万元。 公司募集资金已于 2021 年 9 月 22 日到账，四川华信（集团）会计师事务所 （特殊普通合伙）对公司首次公开发行股票的资金到位情况进行了审验，并于 2021 年 9 月 22 日出具了川华信验（2021）第 0076 号《验资报告》。 公司已对募集资金进行了专户存储，并与保荐机构、存放募集资金的银行签 署了募集资金三方监管协议。 经公司第三届董事会第七次会议、第三届监事会第七次会议和 2022 年第二 次临时股东大会审议，公司决定对"2000 吨/年聚醚酮酮树脂及成型应用项目"中 首期项目进行结项 ...

| 证券代码：301069 | 证券简称：凯盛新材 公告编号：2024-051 | | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | 山东凯盛新材料股份有限公司 （一）募集资金基本情况 经中国证券监督管理委员会 2021 年 8 月 10 日下发的《关于同意山东凯盛 新材料股份有限公司首次公开发行股票注册的批复》（证监许可〔2021〕2626 号），同意公司首次公开发行人民币普通股（A 股）股票 6,000 万股，每股面值 1 元，每股发行价格为人民币 5.17 元，募集资金总额人民币 31,020.00 万元， 扣除与发行有关的费用（不含增值税）人民币 2,830.85 万元，公司实际募集资 金净额为人民币 28,189.15 万元。 公司募集资金已于 2021 年 9 月 22 日到账，四川华信（集团）会计师事务 所（特殊普通合伙）对公司首次公开发行股票的资金到位情况进行了审验，并 于 2021 年 9 月 22 日出具了川华信验（2021）第 0076 号《验资报告》。公司已 对募集资金进行了专户存储，并与保荐机构、存放募集资金的银行签署了《募 集资金三方监管协议》。 ...